InvestSMART

Osteopore Limited (ASX:OSX)

ALERT: Price-sensitive ASX Announcement for OSX
Current share price for OSX : $0.004 -0.001 (-11.11%)+
Announcement
Release
6 Aug 2026 8:45AM
Price at Release
$0.005
Full Release
download
Summary
Osteopore Limited, an Australian-Singaporean regenerative medicine company, announced a significant expansion into the Middle East orthopaedic market. The company has signed a three-year distribution agreement with Al-Umnia Medical LLC, covering Saudi Arabia, United Arab Emirates, Oman, Qatar, and Bahrain. Al-Umnia, founded in Dubai, is a well-established medical technology supplier in the Gulf Cooperation Council region. This agreement marks a strategic move for Osteopore to extend its orthopaedic product line beyond Southeast Asia. The Middle East market presents a substantial growth opportunity for orthopaedic bone regeneration, driven by a high incidence of road trauma and bone sarcomas in the region. Osteopore's partnership with Al-Umnia aims to leverage Al-Umnia's strong regional presence and focus on clinical education to boost market penetration.
Key Points
  • Osteopore signs a 3-year distribution agreement with Al-Umnia Medical LLC.
  • The deal covers Saudi Arabia, UAE, Oman, Qatar, and Bahrain.
  • Al-Umnia is a major medical technology supplier in the GCC region.
  • The GCC orthopaedic devices market is valued at approximately USD 897.5 million in 2025.
  • Osteopore expands orthopaedic product segment into the Middle East.
  • The Middle East market is driven by road trauma and a high incidence of bone sarcomas.
  • Osteopore's technology involves 3D-printed, bioresorbable bone implants.
  • The agreement includes product registration according to each country's regulations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.